-transparent.png){kind=logo}
The cellular localization of the two forms of catechol-O-methyltransferase (COMT) was investigated by measuring their activities in rat striatum following unilateral stereotaxic injection of kainic acid, which causes degeneration of striatal neurons followed by proliferation of astroglial cells. Membrane-bound COMT activity was decreased in the lesioned striatum, while soluble COMT activity was increased. There was a statistically significant correlation between the ratio of lesioned to control activity for membrane-bond COMT and the neuronal marker enzyme glutamate decarboxylase. Similarly the increase in soluble COMT activity paralleled that of the astroglial marker enzyme, glutamine synthetase. These results indicate that the low-Km membrane-bound catechol-O-methyltransferase may be localized predominantly in neurons, whereas the high-Km soluble enzyme is found in glial cells.
A J Rivett, and
A Francis, and
J A Roth
December 1993,
The Biochemical journal,
A J Rivett, and
A Francis, and
J A Roth
March 1999,
Brain research,
A J Rivett, and
A Francis, and
J A Roth
January 1990,
Journal of neural transmission. Supplementum,
A J Rivett, and
A Francis, and
J A Roth
November 1980,
Biochemical pharmacology,
A J Rivett, and
A Francis, and
J A Roth
January 2003,
Methods in molecular biology (Clifton, N.J.),
A J Rivett, and
A Francis, and
J A Roth
September 1987,
Brain research,
A J Rivett, and
A Francis, and
J A Roth
September 1999,
Cancer letters,
A J Rivett, and
A Francis, and
J A Roth
March 1984,
Journal of neurochemistry,
A J Rivett, and
A Francis, and
J A Roth
December 2000,
Archives of biochemistry and biophysics,
A J Rivett, and
A Francis, and
J A Roth
May 1987,
Biochemistry,
